Market Closed -
Toronto S.E.
11:44:32 2024-04-26 EDT
|
5-day change
|
1st Jan Change
|
0.055
CAD
|
+10.00%
|
|
+10.00%
|
+450.00%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
532.1
|
344.7
|
175.7
|
155.6
|
18.26
|
10.13
|
Enterprise Value (EV)
1 |
411.2
|
399.9
|
278.9
|
330.8
|
197.1
|
153.4
|
P/E ratio
|
-6.65
x
|
-3.14
x
|
-1.89
x
|
-4.3
x
|
-0.14
x
|
-0.22
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
71.9
x
|
41.3
x
|
3.46
x
|
1.86
x
|
0.19
x
|
0.1
x
|
EV / Revenue
|
55.6
x
|
47.9
x
|
5.49
x
|
3.95
x
|
2.09
x
|
1.52
x
|
EV / EBITDA
|
-9.81
x
|
-7.28
x
|
-6.98
x
|
-11.2
x
|
-6.39
x
|
-9.15
x
|
EV / FCF
|
-9.02
x
|
-5.74
x
|
-5.21
x
|
-5.31
x
|
51
x
|
13.7
x
|
FCF Yield
|
-11.1%
|
-17.4%
|
-19.2%
|
-18.8%
|
1.96%
|
7.3%
|
Price to Book
|
1.64
x
|
1.28
x
|
0.9
x
|
0.74
x
|
0.2
x
|
0.2
x
|
Nbr of stocks (in thousands)
|
584,769
|
638,250
|
688,944
|
840,885
|
913,008
|
1,013,138
|
Reference price
2 |
0.9100
|
0.5400
|
0.2550
|
0.1850
|
0.0200
|
0.0100
|
Announcement Date
|
19-03-29
|
20-04-29
|
21-04-26
|
22-03-31
|
23-03-31
|
24-03-25
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
7.401
|
8.352
|
50.8
|
83.83
|
94.47
|
101.1
|
EBITDA
1 |
-41.91
|
-54.97
|
-39.98
|
-29.46
|
-30.86
|
-16.77
|
EBIT
1 |
-43.97
|
-62.58
|
-47.1
|
-38.94
|
-48.98
|
-25.95
|
Operating Margin
|
-594.11%
|
-749.23%
|
-92.72%
|
-46.45%
|
-51.84%
|
-25.67%
|
Earnings before Tax (EBT)
1 |
-69.52
|
-119.6
|
-88.11
|
-50.24
|
-136.6
|
-47.75
|
Net income
1 |
-66.99
|
-102.6
|
-85.43
|
-33.74
|
-130.3
|
-44.51
|
Net margin
|
-905.12%
|
-1,228.14%
|
-168.17%
|
-40.25%
|
-137.92%
|
-44.04%
|
EPS
2 |
-0.1368
|
-0.1720
|
-0.1353
|
-0.0431
|
-0.1464
|
-0.0449
|
Free Cash Flow
1 |
-45.61
|
-69.63
|
-53.48
|
-62.31
|
3.864
|
11.2
|
FCF margin
|
-616.33%
|
-833.65%
|
-105.29%
|
-74.33%
|
4.09%
|
11.08%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19-03-29
|
20-04-29
|
21-04-26
|
22-03-31
|
23-03-31
|
24-03-25
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
---|
Net sales
1 |
24.49
|
29.32
|
22.63
|
27.34
|
19.83
|
24.68
|
23.97
|
21.99
|
28.21
|
EBITDA
1 |
-6.85
|
-6.043
|
-5.622
|
-3.995
|
-5.776
|
-0.783
|
0.138
|
-1.078
|
0.117
|
EBIT
|
-9.128
|
-12.62
|
-12.34
|
-12.99
|
-10.46
|
-
|
-
|
-
|
-
|
Operating Margin
|
-37.27%
|
-43.05%
|
-54.53%
|
-47.53%
|
-52.73%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-13.53
|
-18.38
|
-42.8
|
-14.37
|
-62.21
|
-
|
-
|
-
|
-
|
Net income
|
-13.53
|
-18.38
|
-39.85
|
-14.29
|
-60.1
|
-
|
-
|
-
|
-
|
Net margin
|
-55.23%
|
-62.68%
|
-176.11%
|
-52.27%
|
-303.09%
|
-
|
-
|
-
|
-
|
EPS
|
-0.0200
|
-0.0200
|
-0.0500
|
-0.0200
|
-0.0700
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-11-15
|
22-03-31
|
22-05-16
|
22-08-15
|
22-11-14
|
23-03-31
|
23-05-15
|
23-08-14
|
23-11-13
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
55.3
|
103
|
175
|
179
|
143
|
Net Cash position
1 |
121
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-1.006
x
|
-2.581
x
|
-5.948
x
|
-5.795
x
|
-8.546
x
|
Free Cash Flow
1 |
-45.6
|
-69.6
|
-53.5
|
-62.3
|
3.86
|
11.2
|
ROE (net income / shareholders' equity)
|
-35%
|
-37.3%
|
-38.6%
|
-23%
|
-88.7%
|
-65.1%
|
ROA (Net income/ Total Assets)
|
-9.93%
|
-8.97%
|
-7.45%
|
-5.87%
|
-7.83%
|
-5.46%
|
Assets
1 |
674.5
|
1,144
|
1,146
|
574.9
|
1,665
|
814.8
|
Book Value Per Share
2 |
0.5500
|
0.4200
|
0.2800
|
0.2500
|
0.1000
|
0.0500
|
Cash Flow per Share
2 |
0.3700
|
0.0700
|
0.0300
|
0.0200
|
0.0200
|
0.0200
|
Capex
1 |
17.5
|
34.1
|
20.7
|
0.38
|
9.19
|
1.6
|
Capex / Sales
|
236.33%
|
408.32%
|
40.81%
|
0.45%
|
9.73%
|
1.59%
|
Announcement Date
|
19-03-29
|
20-04-29
|
21-04-26
|
22-03-31
|
23-03-31
|
24-03-25
|
|
1st Jan change
|
Capi.
|
---|
| +450.00% | 50.28M | | +35.04% | 5.92B | | -15.13% | 4.51B | | -9.75% | 3.15B | | +2.14% | 3.1B | | -6.82% | 2.42B | | +47.87% | 1.97B | | -7.89% | 1.68B | | +0.09% | 1.65B | | -12.97% | 1.53B |
Alternative Medicine
|